XML 31 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS
12 Months Ended
Dec. 31, 2016
Valuation and Qualifying Accounts [Abstract]  
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
Allowance for Doubtful Accounts
(In thousands)
 
 
 
Charges
 
 
 
 
 
 
 
 
Balance at
 
to Costs,
 
Write-off
 
 
 
Balance
 
 
Beginning
 
Expenses
 
of Accounts
 
 
 
at End of
Description
 
of period
 
and other
 
Receivable
 
Other (1)
 
Period
Year ended December 31, 2014
 
$
47,745

 
$
14,167

 
$
27,014

 
$
(2,502
)
 
$
32,396

Year ended December 31, 2015
 
$
32,396

 
$
30,579

 
$
26,310

 
$
(1,776
)
 
$
34,889

Year ended December 31, 2016
 
$
34,889

 
$
27,390

 
$
27,898

 
$
(499
)
 
$
33,882

(1)
Primarily foreign currency adjustments and acquisition and/or divestiture activity.

Deferred Tax Asset Valuation Allowance
(In thousands)
 
 
 
Charges
 
 
 
 
 
 
 
 
Balance at
 
to Costs,
 
 
 
 
 
Balance
 
 
Beginning
 
Expenses
 
 
 
 
 
at end of
Description
 
of Period
 
and other (1)
 
Reversal (2)
 
Adjustments (3)
 
Period
Year ended December 31, 2014
 
$
327,623

 
$
356,583

 
$
(230
)
 
$
(28,318
)
 
$
655,658

Year ended December 31, 2015
 
$
655,658

 
$
314,098

 
$
(457
)
 
$
(24,723
)
 
$
944,576

Year ended December 31, 2016
 
$
944,576

 
$
109,285

 
$
(49,577
)
 
$
(13,062
)
 
$
991,222


(1)
During 2014, 2015 and 2016, the Company recorded valuation allowances on deferred tax assets attributable to net operating losses in certain foreign jurisdictions.  In addition, during 2015 and 2016 the Company recorded a valuation allowance of $305.3 million and $61.5 million, respectively, on a portion of its deferred tax assets attributable to federal and state net operating loss carryforwards due to the uncertainty of the ability to utilize those losses in future periods.
(2)
During 2014, 2015 and 2016, the Company realized the tax benefits associated with certain foreign deferred tax assets, primarily related to foreign loss carryforwards, on which a valuation allowance was previously recorded.  The associated valuation allowance was reversed in the period in which, based on the weight of available evidence, it is more-likely-than-not that the deferred tax asset will be realized. During 2016, the Company released valuation allowances in France in the amount of $43.3 million.
(3)
During 2014, 2015 and 2016, the Company adjusted certain valuation allowances as a result of changes in tax rates in certain jurisdictions and as a result of the expiration of carryforward periods for net operating loss carryforwards.